10 AbbVie finance leaders
Seven areas of AbbVie finance each have a finance director in these titles: R&D oncology, Bay Area R&D, operations HQ, AbbVie Logistics B.V., IMCO, FP&A and US immunology price forecasting for Skyrizi and Rinvoq, while one Vice President, Commercial Controller covers the commercial side. All ten hold current AbbVie roles, useful for pharma finance teams deciding how to support brands, research portfolios and plants.
Professionals to explore
Audrey Nicoll
LinkedInExperience: Finance Director - US Immunology Price Forecasting (Skyrizi & Rinvoq) · AbbVie
$269 per 30-minute call
Audrey Nicoll holds Finance Director - US Immunology Price Forecasting (Skyrizi & Rinvoq) at AbbVie (since 2025), and was Finance Director, US Commercial - GI & Est Products (2023-2025) and Associate Director, US Commercial FP&A (2020-2023). Takeda Pharmaceuticals titles include Finance Director - Shire Integration - US Business Unit (2019-2020), a fit for brand forecasting and integration finance.
Is this you? Claim your profile and get paid for calls.
Carol Shi
LinkedInExperience: Finance Director, AbbVie Logistics B.V. · AbbVie
$269 per 30-minute call
Carol Shi has been Finance Director, AbbVie Logistics B.V. since 2026 and was Finance Director, Asia at AbbVie (2018-2026). AstraZeneca roles include Area Compliance Director- Asia Area & ANZ (2016-2018), CFO, Thailand (2013-2016) and Regional Finance Lead-FP&A (2012-2013), which suits regional and country finance questions in Asia.
Is this you? Claim your profile and get paid for calls.
Cathy Gorecki
LinkedInExperience: Finance Director, FP&A · AbbVie
$269 per 30-minute call
With Finance Director, FP&A at AbbVie since 2025 and Strategic Pricing Director, Immunology (2022-2025), Cathy Gorecki also held Finance Director - Operations at AbbVie (2020-2022). Outside AbbVie, Cathy was Finance Director - Healthcare Development & Market Access at Walgreens (2017-2020) and Director, Operations Finance at GATX (2013-2017), plus a role as functional controller for 11 fixed facility plants.
Is this you? Claim your profile and get paid for calls.
Clara Schlusselblum
LinkedInExperience: Finance Director, IMCO · AbbVie
$269 per 30-minute call
Clara Schlusselblum has been Finance Director, IMCO at AbbVie since 2026, and was Immunology Finance Business Partner, Intercontinental (2022-2025), FP&A Manager - LATAM (2020-2022) and Planning & Demand Manager - Region South (2019-2020) at AbbVie, and Commercial Controller at Abbott (2015-2018), a fit for finance business partnering on immunology and for LATAM planning.
Is this you? Claim your profile and get paid for calls.
Drew Mixon
LinkedInExperience: Finance Director, Operations HQ · AbbVie
$269 per 30-minute call
Finance Director, Operations HQ at AbbVie since 2026. Drew Mixon joined AbbVie through its two-year rotational Finance Development Program, with titles including Associate Director, Finance Special Projects (2025-2026), Associate Director - Inventory Analytics, Reporting & Systems (2023-2025), VLOG Finance Integration Lead (2021-2023) and Assistant Finance Controller - VLOG Hedging & NPI (2019-2021), useful for operations finance and inventory reporting.
Is this you? Claim your profile and get paid for calls.
Itamar Seindlis
LinkedInExperience: Director of Finance CFO · AbbVie
$269 per 30-minute call
Director of Finance CFO at AbbVie since 2024, described as CFO at AbbVie Israel. Itamar Seindlis was CFO Sanofi Israel at Sanofi (2020-2025) and Head of accounting & Tax there (2016-2020), and was Senior Audit Associate (2011-2014) and Manager Audit Associate (2015-2016) at EY; experience in manufacturing operations, strategic planning and financial controllership is also listed, useful for country CFO questions.
Is this you? Claim your profile and get paid for calls.
Jennifer Cruden, CPA
LinkedInExperience: Director, Abbvie Bay Area R&D Finance · AbbVie
$471 per 30-minute call
Jennifer Cruden, CPA, is Director, Abbvie Bay Area R&D Finance (since 2025) and was Associate Director, R&D Finance (2020-2025). At Pharmacyclics, an AbbVie Company, the titles were Senior Manager - Financial Planning & Analysis (2018-2020) and Senior Manager of Accounting (2016-2018), after Assurance Manager at EY (2010-2016), suited to R&D site finance questions.
Is this you? Claim your profile and get paid for calls.
Jill Franks
LinkedInExperience: Vice President, Commercial Controller · AbbVie
$1,211 per 30-minute call
As Vice President, Commercial Controller (since 2024), Jill Franks is finance controller and business partner for AbbVie's Global Commercial organization. Earlier AbbVie titles were Vice President, US Immunology Finance (2022-2024), US Oncology Controller (2020-2022), Director, Finance (2019-2020) and Director, FP&A and Entity Planning (2015-2019), covering P&L decision support on the commercial side.
Is this you? Claim your profile and get paid for calls.
Mike Thiel
LinkedInExperience: Finance Director, FP&A · AbbVie
$438 per 30-minute call
Mike Thiel has been Finance Director, FP&A at AbbVie since 2026, after Associate Director, Finance (2023-2026), Finance Manager, Operations FP&A (2022-2023) and Supervisor, Global Consolidations & Reporting (ACOE) (2020-2022). Manager & Team Leader at The Siegfried Group (2019-2020) precedes it, so operations FP&A and consolidation reporting are the fit.
Is this you? Claim your profile and get paid for calls.
Steven Voit
LinkedInExperience: Director, Finance R&D Oncology and OED · AbbVie
$471 per 30-minute call
Steven Voit is Director, Finance R&D Oncology and OED at AbbVie (since 2026), following Associate Director, R&D Portfolio FP&A (2025-2026), Senior Finance Manager - R&D Externals Therapeutics FP&A (2024-2025) and Finance Manager - Global Supply Chain (2022-2024). Financial analytics, Power BI and finance transformation are named specialties, a fit for R&D portfolio planning.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For R&D portfolio finance, talk to Steven Voit or Jennifer Cruden; for operations and supply chain finance, Drew Mixon, Mike Thiel or Cathy Gorecki. Commercial brand questions fit Jill Franks or Audrey Nicoll, and Carol Shi, Clara Schlusselblum and Itamar Seindlis cover country and regional finance outside the US.
Questions to take into the conversation
- 01How does AbbVie finance decide how much R&D spend to put behind an oncology program before it reaches late-stage trials?
- 02What does price forecasting for an immunology brand involve at AbbVie, and how does it feed the commercial plan?
- 03How is finance support for AbbVie's operations and logistics entities organized differently from support for commercial brands?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.